pT3TS-RfxCas13d-2C-NLS
(Plasmid
#239816)
-
PurposePlasmid to carry out IVT of RfxCas13d with SV40 and nucleoplasmin long-NLP NLS (human codon-optimized)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 239816 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backbonepT3TS
- Backbone size w/o insert (bp) 3118
- Total vector size (bp) 6115
-
Vector typeCRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameRfx-Cas13d
-
Alt nameCasRx
-
SpeciesRuminococcus flavefaciens XPD3002
-
Insert Size (bp)2997
-
Tags
/ Fusion Proteins
- SV40 NLS (C terminal on insert)
- Nucleoplasmin long NLS (C terminal on insert)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byAddgene plasmid #141320 used as template
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This plasmid is owned by Moreno-Mateos Lab (CABD, Seville, Spain)
Please note: This plasmid contains proline as the third amino acid of nucleoplasmin NLS. This is a known variant of nucleoplasmin NLS that does not impact its function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pT3TS-RfxCas13d-2C-NLS was a gift from Miguel Angel Moreno-Mateos (Addgene plasmid # 239816 ; http://n2t.net/addgene:239816 ; RRID:Addgene_239816) -
For your References section:
Enhanced RNA-targeting CRISPR-Cas technology in zebrafish. Moreno-Sanchez I, Hernandez-Huertas L, Nahon-Cano D, Martinez-Garcia PM, Treichel AJ, Gomez-Marin C, Tomas-Gallardo L, da Silva Pescador G, Kushawah G, Egidy R, Perera A, Diaz-Moscoso A, Cano-Ruiz A, Walker JA 2nd, Munoz MJ, Holden K, Galceran J, Nieto MA, Bazzini AA, Moreno-Mateos MA. Nat Commun. 2025 Mar 16;16(1):2591. doi: 10.1038/s41467-025-57792-9. 10.1038/s41467-025-57792-9 PubMed 40091120